Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03321201

Cauterization Versus Fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Led by University of Split, School of Medicine · Updated on 2022-11-02

164

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

Sponsors

U

University of Split, School of Medicine

Lead Sponsor

U

University Hospital of Split

Collaborating Sponsor

AI-Summary

What this Trial Is About

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea that can progress to cause vision problems, eye movement restrictions, chronic inflammation, and cosmetic issues. This clinical trial evaluates and compares two methods for securing conjunctival autografts during primary pterygium surgery: cauterization and fibrin glue. The study is randomized and controlled to assess which method may influence recurrence rates and other outcomes. The two interventions studied are cauterization, where a bipolar cutter is used to secure the graft with controlled cauterizing wraps, and fibrin glue, where a fiber adhesive is prepared and applied to fix the graft. The fibrin glue preparation takes about 10 to 15 minutes and is performed by a nurse. Both procedures aim to secure the conjunctival autograft during surgery to prevent recurrence. Participants will be followed for 180 days after surgery to monitor the recurrence of pterygium, surgical time, complication rates, astigmatism caused by pterygium, ocular surface condition, and postoperative symptoms such as discomfort, tearing, pain, and foreign body sensation. Pain and economic analyses will also be assessed at various time points including 7, 30, and 180 days after surgery. The study includes triple masking and random allocation to study groups.

CONDITIONS

Brief Title

Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults older than 18 years of age
  • Both sexes
  • Primary nasal pterygia measuring 4 mm or more that tends to increase, including patients with reduced visual acuity, chronic inflammation, or cosmetic reasons
  • If bilateral pterygium is present, only one eye will be operated
Not Eligible

You will not qualify if you...

  • Connective tissue disease
  • Prior eye surgery
  • Chronic use of topical drugs such as anti-glaucoma medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery

Duration - Day of surgery

Participants undergo primary pterygium surgery with conjunctival autografting using either cauterization or fibrin glue to secure the graft.

1 surgery visit (in-person)

Post-operative Follow-up

Duration - 180 days

Participants are monitored for surgical outcomes, complications, pain, and ocular surface condition after surgery.

Visits at 7, 30, and 180 days post-surgery

Trial Site Locations

Total: 1 location

1

University Hospital Split

Split, Croatia, 21000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Cauterisation versus fibrin glue for conjunctival autografting in primary pterygium surgery (CAGE CUP): study protocol of a randomised controlled trial.

Mladen Lešin, Martina Paradžik, Josipa Marin Lovrić...

https://pubmed.ncbi.nlm.nih.gov/29950464